Mental Health

The benefits of psychedelic medicine could expand into long-lasting and transformative therapeutics to treat depression better than selective serotonin reuptake inhibitors (SSRIs).

New research suggests that ketamine can help rehabilitate those who suffer from an eating disorder, and it is important to recognize the root cause of this mental health crisis.

Experts discuss the clinical and economic impact of misdiagnosing bipolar I disorder as major depressive disorder.

New research finds that mental health has replaced COVID-19 as the top health concern among Americans, but deeper analysis needs to be done into whether depression and anxiety are truly becoming more widespread.

Male students admitted into a high-performing public charter school found to have better physical health and lower body mass index than their female counterparts.

New research suggests that MDMA may offer promising benefits to patients with certain unmet psychological treatment needs.

New research suggests that psychedelics, and specifically ketamine, can increase neuroplasticity to help a patient with an eating disorder get “unstuck,” and help treat the disorder better than psychotherapy alone.

Pharmacists play an important role in the recovery journey for patients who decide medication assisted treatment is right for them.

The research further supports zuranolone as a potential episodic treatment for people with MDD, according to the study authors.

Pharmacists dispensing Lybalvi should understand that potentially life-threatening consequences can occur if opioids are taken concurrently.

Following the success of the phase 3 EMERGENT-2 trial, researchers suggest that xanomeline-trospium could be a safe and effective treatment option for adults with schizophrenia.

Many drugs for these conditions enter clinical trials, but few demonstrate success.

Using your voice as a health care professional and supporting each other through burnout are just a few ways to better advocate in the profession.

The New Drug Application for aripiprazole 2-month, ready-to-use, long-acting injectable could lead to the first FDA approval of a 2-month schizophrenia and bipolar I disorder antipsychotic treatment.

Although serotonin is widely associated with feelings of happiness, a study suggests it may be associated with the severity of COVID-19.

Scientists may be able to minimize adverse effects while gaining a better understanding of psychedelic medicines' efficacy and durability.

University of California Irvine investigators spotlight links and propose further systematic examination into the molecular underpinnings.

The mainstay of treatment for schizophrenia and schizoaffective disorder includes antipsychotics.

Addiction to checking the news can worsen mental and physical illness, and in many cases may require individuals to reduce, or even stop, consuming any news.

Study results show that the risk of gaining 10% or more of body weight from the baseline fell 50% when patients were on the combination.

Data have shown there is a rising need for mental health and substance use disorder services, yet there is a shortage of psychiatrists in the country that is estimated to worsen by 2024.

Pregnant women with epilepsy showed more symptoms of anxiety and depression than healthy pregnant or non-pregnant women, but mental health screening may help.

Industry partnerships will be essential to improving access to ketamine, according to expert Kevin Nicholson.

Routine depression screening in the primary care setting lowered screening disparities and increased recognition of symptoms for groups at risk of undertreatment, including racial and ethnic minority individuals and patients of older age.

A systematic review of literature found that family history of psychiatric disorders is a risk factor associated with postpartum depression, adding to a contradictory body of research.

Auvelity is a combination of dextromethorphan and bupropion indicated for the treatment of major depressive disorder in adults.

Investigators also report that the therapy could mimic the efficacy of olanzapine but cancelled out the medication-induced weight gain, improving symptoms and outcomes.

Narcissistic leaders have a negative impact on the culture of their organization as their conduct and management style induces fear.

Auvelity uses the first new oral mechanism of action for major depressive disorder in more than 60 years.

Pharmacies can play a key role in supporting patients with opioid use disorder and helping diminish stigma for patients treated with methadone, who are told by some they are still addicts despite trying to receive help.